top of page
Search
Glenn Hearson
Nov 11, 2019
Midlands ILD (MILD) Fibrosis Meeting 2019 Brochure Now available
The brochure for the Midlands ILD Fibrosis (MILD) Meeting, being held in the beautiful Trent Building at the University of Nottingham campus
36
Glenn Hearson
Aug 20, 2019
Dr Jennifer Cairns:Investigating Elk-1 Mediated Molecular Mechanisms
Dr Jennifer Cairns:Investigating Elk-1 Mediated Molecular Mechanisms
401
Glenn Hearson
May 16, 2019
Well Done @lucyjhoward and @GauriSaini6 in Recruiting the Final Participant into IPF JES Study
Well Done @lucyjhoward and @GauriSaini6 in Recruiting the Final Participant into IPF JES Study
43
Glenn Hearson
Sep 6, 2018
NIHR Nottingham BRC Research; It’s Not JUST Idiopathic Pulmonary FibrosiS Study (INJUSTIS)
New NIHR Nottingham BRC Research; It’s Not JUST Idiopathic Pulmonary FibrosiS Study (INJUSTIS)
217
Glenn Hearson
Jan 3, 2018
Celgene CC-90001-IPF-001Research Study
The Joint Respiratory Research Day will take place on 2nd May 2018 at Stamford Court, Leicester
497
Glenn Hearson
Dec 8, 2017
The Efficacy and Mechanism Evaluation of Treating IPF with the addition of Co-trimoxazole
The Efficacy and Mechanism Evaluation of Treating IPF with the addition of Co-trimoxazole
160
Glenn Hearson
Dec 8, 2017
Idiopathic Pulmonary Fibrosis Job Exposure Study (IPF JES)
IPF JES is a research study that aims to discover if workplaces are a cause of idiopathic pulmonary fibrosis (IPF). Dr Gauri Saini leading
101
Glenn Hearson
Nov 7, 2016
Understanding the mechanisms of idiopathic pulmonary fibrosis in order to develop new treatments
IPF is a progressive and devastating lung disorder characterised by irreversible scarring (fibrosis) of the lung. IPF affects over 8,000 peo
65
bottom of page